Financial Incentives for Smoking Cessation in Pregnancy
Trial Summary
What is the purpose of this trial?
Although many women initially quit smoking during pregnancy, most will return to smoking by the end of pregnancy or during the first 6 months postpartum. The proposed pilot project is designed to evaluate the feasibility and potential efficacy of offering small financial incentives for the completion of smoking cessation coaching and biochemically-verified smoking abstinence at follow-up among pregnant women with Medicaid insurance who contact the Oklahoma Tobacco Helpline (OTH). The study will enroll 100 pregnant women who will be randomly assigned to OTH care or OTH plus escalating incentives (OTH+I) for completing up to 5 coaching calls over the first 8 weeks after enrolling (prepartum) and for biochemically-verified smoking abstinence at 9 weeks post-enrollment (assessed remotely via smartphone). In addition, participants will be incentivized for completing a postpartum coaching call by 8 weeks postpartum. Feasibility outcomes for the incentives based intervention will focus on coaching call completion, rates of prepartum and postpartum follow-up, biochemically-verified smoking cessation, and perceptions of the intervention. Potential effectiveness will be evaluated by comparing biochemically-verified smoking abstinence rates in OTH+I relative to OTH alone at 12 weeks post-enrollment (prepartum) and 12 weeks postpartum.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on smoking cessation and does not mention any medication restrictions.
What data supports the effectiveness of the treatment Standard Care + Financial Incentives for smoking cessation in pregnancy?
Is it safe to use financial incentives for smoking cessation during pregnancy?
How does the treatment of Standard Care + Financial Incentives for smoking cessation in pregnancy differ from other treatments?
This treatment is unique because it combines standard care with financial incentives to encourage pregnant women to quit smoking, which has been shown to be the most effective intervention for smoking cessation during pregnancy. Unlike other treatments, it directly motivates behavior change through monetary rewards, making it both effective and cost-effective.34678
Eligibility Criteria
This trial is for pregnant women under 25 weeks along, who smoke at least 5 cigarettes daily, are over 18 years old, speak English, and have Medicaid. They must be seeking smoking cessation treatment through the Oklahoma Tobacco Helpline and willing to enroll in a program involving multiple calls.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prepartum Treatment
Participants receive up to 5 coaching calls over the first 8 weeks after enrolling, with financial incentives for completion and biochemically-verified smoking abstinence at 9 weeks post-enrollment
Postpartum Treatment
Participants are incentivized for completing a postpartum coaching call by 8 weeks postpartum
Follow-up
Participants are monitored for biochemically-verified smoking abstinence at 12 weeks post-enrollment and 12 weeks postpartum
Treatment Details
Interventions
- Standard Care + Financial Incentives
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor